In March 2015, the Ministry of Science and Technology held the first national expert meeting on precision medicine strategy and proposed the China Precision Medical Plan. The meeting pointed out that by 2030, China will invest 60 billion yuan in precision medicine .
In March 2016, precision medicine was included in the national key research and development project, and will promote the entry of precision medicine into the medical insurance catalogue, which is expected to break the key bottleneck of large-scale commercialization of precision medicine, and the whole industry may usher in an explosive growth opportunity in the next few years.
In this case, the development of precision medical treatment is not smooth sailing. In fact, there are still many pain points in the whole industry.
One of the most fundamental and fundamental problems faced by precision medicine stems from the technology itself.
In order to promote the popularization of precision medicine, it is necessary to promote the medical technology level of precision medicine, so as to solve the problem of gene sequencing , data analysis, and heterogeneity of patient groups in precision medicine, and the treatment of precision medicine. The cost can be gradually reduced.
To this end, Tongdu Capital will hold the “Dongdu Time-Precision Medical-Innovative Technology and Business Model Salon in the Oncology Field†in Beijing on the afternoon of July 7, 2016. Yang Chengkui, vice president of Tongdu Capital Investment, will release the latest smart health startup and investment and financing analysis report for the second quarter of 2016, sharing a lot of latest development data on smart health. (This report is a quarterly series report written by Tongdu Capital. It mainly summarizes and predicts the development of entrepreneurship and investment and financing in the field of smart health through the analysis of market segments.)
At that time, Mr. Sun Wenxiang from Lekang Think Tank will bring a policy interpretation of the latest report; Mr. Gao Xianshu, Director of the Department of Radiotherapy, Peking University First Hospital, and Mr. Hu Zhiyuan, Director of the Nano Translational Medicine Laboratory of the National Nanoscience Center will also bring a wonderful keynote speech. Share the deep understanding between the oncology field and the business model with everyone. The founders, CEOs and capitalists of many Internet medical projects have gathered together to discuss the new opportunities for the treatment of cancer in the field of precision medicine. What innovative business models are emerging?
Cumin Powder In Hindi,Cumin Powder In Malay,Cumin Powder In Malayalam,Cumin Seed Powder
jiangmen city hongsing food co., ltd. , https://www.jmhongsing.com